Header Logo

Connection

David Ciesla to Caspase Inhibitors

Back to Details
This is a "connection" page, showing publications David Ciesla has written about Caspase Inhibitors.
David Ciesla
Connection Strength
0.014
Caspase Inhibitors
  1. Clinically relevant hypertonicity prevents stored blood- and lipid-mediated delayed neutrophil apoptosis independent of p38 MAPK or caspase-3 activation. Surgery. 2003 Jul; 134(1):86-91.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.